Accretion Nutraveda AGM resolutions pass with unanimous shareholder support
- Accretion Nutraveda shareholders unanimously approved all 10 resolutions at its 5th AGM
- Standalone financial statements for FY26 were adopted with 5.32 million votes in favor
- Two new independent directors, Chand Kanabar and Grishma Shewale, were appointed
- Remuneration revisions for six key executives received 100% shareholder support

*this image is generated using AI for illustrative purposes only.
Accretion Nutraveda Limited declared the voting results for its fifth annual general meeting held on August 27, 2026. Shareholders unanimously approved all ten resolutions proposed at the gathering.
The meeting, conducted via video conferencing, saw shareholders adopt the standalone financial statements for FY26 and approve key board changes. The scrutinizer report confirmed that all resolutions received 100% of the votes cast in their favor, with no votes against or invalid votes recorded.
Voting Results Overview
The remote e-voting facility was open from August 24 to August 26, 2026. Members who did not vote remotely were given a window to cast electronic votes during the meeting. Mr. Nimish Chunibhai Sakhya served as the scrutinizer for the process.
The consolidated results for the key resolutions are detailed below:
| Resolution Type | Key Outcome | Votes in Favor | % Support |
|---|---|---|---|
| Ordinary | Adoption of FY26 Financial Statements | 5,322,000 | 100% |
| Ordinary | Reappointment of Vivek Ashokkumar Patel | 4,524,000 | 100% |
| Special | Appointment of Chand Rameshbhai Kanabar (Ind. Dir.) | 5,322,000 | 100% |
| Special | Appointment of Grishma A Shewale (Ind. Dir.) | 5,322,000 | 100% |
| Special | Remuneration Revision for Managing Director | 4,524,000 | 100% |
Board and Governance Updates
Shareholders approved the reappointment of Mr. Vivek Ashokkumar Patel as a director retiring by rotation. Additionally, the company secured approval for the appointment of two new independent directors: Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale.
The Board also obtained unanimous approval for revised remuneration packages for several key executives. These revisions covered:
- Mr. Mayur Popatlal Sojitra (Managing Director)
- Mr. Paraskumar Vinubhai Parmar (CFO and Director)
- Mr. Ankurkumar Shantilal Patel (Whole-Time Director)
- Mr. Harshad Nanubhai Rathod (Director)
- Mr. Vivek Ashokkumar Patel (Director)
- Mr. Hardik Mukundbhai Prajapati (Director)
Audit and Compliance
The statutory auditor, CA Dr. Vishves Shah, and secretarial auditor, Mr. Nimish Sakhija, were present at the meeting. The audit reports for the year ended March 31, 2026, contained no qualifications or adverse observations. Consequently, these reports were not read out during the meeting, adhering to standard procedural requirements under the Companies Act, 2013.
Mr. Harshad Rathod, Chairman and Director, presided over the proceedings, which commenced at 2:00 pm and concluded at 2:18 pm.
Historical Stock Returns for Accretion Nutraveda
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.27% | -0.98% | 0.0% | 0.0% | 0.0% | 0.0% |
How will the appointment of new independent directors Chand Rameshbhai Kanabar and Grishma A Shewale influence Accretion Nutraveda's strategic direction and corporate governance standards?
What specific performance metrics or growth targets are likely tied to the revised remuneration packages approved for the Managing Director and other key executives?
Given the unanimous approval of FY26 financials, what are the projected revenue growth and margin expansion targets for Accretion Nutraveda in the upcoming fiscal year?































